Purchase Of Chemical Reagents, Diagnostic Kits, Glass, Metal, Plastic, Immunoaffinity Columns, Solid Phase Extraction Columns And Other Products Used For Chemical Research
Upgrade to view
Lithuania
31-12-2039
Tender Notice
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Alirocumab (C10Ax14) Within The Framework Of A So-Called Open-House Model.
Upgrade to view
Germany
31-05-2026
Tender Notice
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Ustekinumab (L04Ac05) Within The Framework Of A So-Called Open-House Model.
Upgrade to view
Germany
31-05-2026
Tender Notice
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredients Dolutegravir And Rilpivirine (J05Ar21) Within The Framework Of A So-Called Open-House Model.
Upgrade to view
Germany
31-05-2026
Tender Notice
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Naloxegol (A06Ah03) Within The Framework Of A So-Called Open-House Model.
Upgrade to view
Germany
31-05-2026
Tender Notice
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Etanercept (L04Ab01) Within The Framework Of A So-Called Open-House Model.
Upgrade to view
Germany
31-05-2026
Tender Notice
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Lisdexamfetamine (N06Ba12) Within The Framework Of A So-Called Open-House Model.
Upgrade to view
Germany
31-05-2026
Tender Notice
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Tacrolimus (L04Ad02) Within The Framework Of A So-Called Open-House Model.
Upgrade to view
Germany
30-04-2026
Tender Notice
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Sirolimus (L04Ah01) Within The Framework Of A So-Called Open-House Model.
Upgrade to view
Germany
30-04-2026
Tender Notice
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Lipegfilgrastim (L03Aa14) Within The Framework Of A So-Called Open-House Model.
Upgrade to view
Germany
30-04-2026
Tender Notice